首页> 外文OA文献 >Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

【2h】

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

机译：核糖核苷酸还原酶亚单位M1对胰腺癌患者患者的临床意义，其吉西他滨佐剂化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Toru Aoyama; Yohei Miyagi; Masaaki Murakawa; Koichiro Yamaoku; Yosuke Atsumi; Manabu Shiozawa; Makoto Ueno; Manabu Morimoto; Takashi Oshima; Norio Yukawa; Takaki Yoshikawa; Yasushi Rino; Munetaka Masuda; Soichiro Morinaga;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine [J] . Aoyama Toru, Miyagi Yohei, Murakawa Masaaki, Oncology letters . 2017,第5aPta2期

机译：核糖核苷酸还原酶亚单位M1对治疗切除术后胰腺癌患者的临床意义，随后用吉西他滨的佐剂化疗
2. Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection [J] . NakagawaN., MurakamiY., UemuraK., Surgery . 2013,第4期

机译：肿瘤内人类平衡核苷转运蛋白1（hENT1）和核糖核苷酸还原酶调节亚基M1（RRM1）表达的联合分析是手术切除后接受吉西他滨辅助化疗的胰腺癌患者生存的有力预测指标
3. Clinical Implication of Peritoneal Cytology in the Pancreatic Cancer Patients who underwent Curative Resection followed by Adjuvant Gemcitabine or S-1 Chemotherapy [J] . Aoyama Toru, Katayama Yusuke, Murakawa Masaaki, Hepato-gastroenterology. . 2015,第137期

机译：接受根治性吉西他滨或S-1化疗辅助治疗的胰腺癌患者腹膜细胞学的临床意义
4. Design, Synthesis and Structure of Peptidomimetic Inhibitors of Eukaryotic Ribonucleotide Reductase: A Target for Cancer Chemotherapy [C] . Jaskiran Kaur, Shalini Jha, Chris Dealwis American Peptide Symposium . 2009

机译：真核核糖核苷酸还原酶肽抑制剂的设计，合成和结构：癌症化疗靶标
5. The Effects of Adjuvant Chemotherapy on Brain Function in Breast Cancer Patients and a Cancer-Chemotherapy Rodent Model. [D] . Barr, Alicia Thomas. 2014

机译：辅助化疗对乳腺癌患者脑功能的影响和癌症化学疗法的啮齿动物模型。
6. Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine [O] . Toru Aoyama, Yohei Miyagi, Masaaki Murakawa, -1

机译：接受根西他滨辅助化疗的根治性切除术后胰腺癌患者中核糖核苷酸还原酶M1亚基的临床意义
7. Combined analysis of intratumoral human equilibrative nucleoside transporter 1 (hENT1) and ribonucleotide reductase regulatory subunit M1 (RRM1) expression is a powerful predictor of survival in patients with pancreatic carcinoma treated with adjuvant gemcitabine-based chemotherapy after operative resection [O] . Naoya Nakagawa, Yoshiaki Murakami, Kenichiro Uemura, 2013

机译：肿瘤内核苷酸转运蛋白1（HENT1）和核糖核苷酸还原酶调节亚单位M1（RRM1）表达的综合分析是在手术切除后用佐剂吉西他滨的化学疗法治疗胰腺癌患者生存的强烈预测因子

Clinical implications of ribonucleotide reductase subunit M1 in patients with pancreatic cancer who undergo curative resection followed by adjuvant chemotherapy with gemcitabine

著录项

引文网络

相似文献

相关主题

期刊订阅